Artificial Sweeteners Not Tied to Lower BMI and May Even Increase It — Physician’s First Watch

Medical News |
July 17, 2017

Artificial Sweeteners Not Tied to Lower BMI and May Even Increase It

By Kelly Young

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Artificial sweeteners like aspartame and stevioside are not associated with reduced BMI and may pose some risks, suggests a meta-analysis in the Canadian Medical Association Journal.

Researchers identified 37 studies that looked at the effects of artificial sweeteners in 400,000 people over age 12.

In randomized trials with a median 6 months' follow-up, the primary outcome, BMI, was not associated with intake of artificial sweeteners. Three long-term cohort studies suggested a modest increase in BMI over time with increased artificial sweetener consumption. For secondary outcomes like weight, metabolic syndrome, and type 2 diabetes, the observational studies again found higher risk with increased intake.

Dr. Harlan Krumholz, editor-in-chief of NEJM Journal Watch Cardiology, comments: "This study raises the concerning possibility that not only have these sweeteners not helped people manage their weight, but may have actually jeopardized their cardiometabolic health. The evidence base is far too weak to make definitive conclusions, but the urgent need for more information about these common ingredients is obvious."

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.